Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1982 2
1983 2
1985 2
1986 2
1987 1
1988 1
1991 1
1993 2
1994 5
1995 1
1996 4
1997 1
1998 9
1999 3
2000 3
2001 6
2002 4
2003 1
2004 1
2005 1
2006 2
2007 3
2008 2
2009 1
2011 3
2012 1
2013 3
2014 5
2015 9
2016 7
2017 14
2018 7
2019 6
2020 7
2021 20
2022 24
2023 23
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

177 results

Results by year

Filters applied: . Clear all
Page 1
Unraveling KMT2A-rearranged ALL.
Shimony S, Luskin MR. Shimony S, et al. Among authors: luskin mr. Blood. 2023 Nov 23;142(21):1764-1766. doi: 10.1182/blood.2023021942. Blood. 2023. PMID: 37995105 No abstract available.
A Phase Ib/II Study of Ivosidenib with Venetoclax ± Azacitidine in IDH1-Mutated Myeloid Malignancies.
Lachowiez CA, Loghavi S, Zeng Z, Tanaka T, Kim YJ, Uryu H, Turkalj S, Jakobsen NA, Luskin MR, Duose DY, Tidwell RSS, Short NJ, Borthakur G, Kadia TM, Masarova L, Tippett GD, Bose P, Jabbour EJ, Ravandi F, Daver NG, Garcia-Manero G, Kantarjian H, Garcia JS, Vyas P, Takahashi K, Konopleva M, DiNardo CD. Lachowiez CA, et al. Among authors: luskin mr. Blood Cancer Discov. 2023 Jul 5;4(4):276-293. doi: 10.1158/2643-3230.BCD-22-0205. Blood Cancer Discov. 2023. PMID: 37102976 Free PMC article. Clinical Trial.
Prediction of risk for myeloid malignancy in clonal hematopoiesis.
Weeks LD, Niroula A, Neuberg D, Wong W, Lindsley RC, Luskin M, Berliner N, Stone RM, DeAngelo DJ, Soiffer R, Uddin MM, Griffin G, Vlasschaert C, Gibson CJ, Jaiswal S, Bick AG, Malcovati L, Natarajan P, Ebert BL. Weeks LD, et al. Among authors: luskin m. NEJM Evid. 2023 May;2(5):10.1056/evidoa2200310. doi: 10.1056/evidoa2200310. Epub 2023 Apr 25. NEJM Evid. 2023. PMID: 37483562 Free PMC article.
Exploring the Feasibility of a Mindfulness-Music Therapy Intervention to Improve Anxiety and Stress in Adolescents and Young Adults with Cancer.
Knoerl R, Mazzola E, Woods H, Buchbinder E, Frazier L, LaCasce A, Li BT, Luskin MR, Phillips CS, Thornton K, Berry DL, Ligibel JA. Knoerl R, et al. Among authors: luskin mr. J Pain Symptom Manage. 2022 Apr;63(4):e357-e363. doi: 10.1016/j.jpainsymman.2021.11.013. Epub 2021 Dec 8. J Pain Symptom Manage. 2022. PMID: 34896280 Clinical Trial.
A challenging choice: consolidation in Ph+ ALL.
Luskin MR. Luskin MR. Blood. 2022 Nov 17;140(20):2093-2094. doi: 10.1182/blood.2022017793. Blood. 2022. PMID: 36394905 Free article. No abstract available.
Mapping and Monitoring Zero-Deforestation Commitments.
Austin KG, Heilmayr R, Benedict JJ, Burns DN, Eggen M, Grantham H, Greenbury A, Hill JK, Jenkins CN, Luskin MS, Manurung T, Rasmussen LV, Rosoman G, Rudorff B, Satar M, Smith C, Carlson KM. Austin KG, et al. Among authors: luskin ms. Bioscience. 2021 Aug 18;71(10):1079-1090. doi: 10.1093/biosci/biab082. eCollection 2021 Oct. Bioscience. 2021. PMID: 34616238 Free PMC article.
Targeting minimal residual disease: a path to cure?
Luskin MR, Murakami MA, Manalis SR, Weinstock DM. Luskin MR, et al. Nat Rev Cancer. 2018 Apr;18(4):255-263. doi: 10.1038/nrc.2017.125. Epub 2018 Jan 29. Nat Rev Cancer. 2018. PMID: 29376520 Free PMC article. Review.
177 results